ACOG Clinical Practice Guideline No. 5: Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum
The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Abstract
PURPOSE: To assess the evidence regarding safety and efficacy of psychiatric medications to treat mental health conditions during pregnancy and lactation. The conditions reviewed include depression, anxiety and anxiety-related disorders, bipolar disorder, and acute psychosis. For information on screening and diagnosis, refer to American College of Obstetricians and Gynecologists (ACOG) Clinical Practice Guideline Number 4, “Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum” (1). TARGET POPULATION: Pregnant or postpartum individuals with mental health conditions with onset that may have predated the perinatal period or may have occurred for the first time in pregnancy or the first year postpartum or may have been exacerbated in that time. METHODS: This guideline was developed using an a priori protocol in conjunction with a writing team consisting of one specialist in obstetrics and gynecology and one maternal–fetal medicine subspecialist appointed by the ACOG Committee on Clinical Practice Guidelines–Obstetrics and two external subject matter experts. ACOG medical librarians completed a comprehensive literature search for primary literature within Cochrane Library, Cochrane Collaboration Registry of Controlled Trials, EMBASE, PubMed, and MEDLINE. Studies that moved forward to the full-text screening stage were assessed by two authors from the writing team based on standardized inclusion and exclusion criteria. Included studies underwent quality assessment, and a modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into recommendation statements. RECOMMENDATIONS: This Clinical Practice Guideline includes recommendations on treatment and management of perinatal mental health conditions including depression, anxiety, bipolar disorders, and acute postpartum psychosis, with a focus on psychopharmacotherapy. Recommendations are classified by strength and evidence quality. Ungraded Good Practice Points are included to provide guidance when a formal recommendation could not be made because of inadequate or nonexistent evidence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although BZD use during pregnancy may carry some risk to the fetus, similar risks are also present if patient anxiety, mood, and sleep disorders are left untreated, including an increase in miscarriage, preterm birth, and low birth weight.175,186”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [186]
In the citing paper
“ACOG has noted that186(1278):[I]t is also critical to consider the risks of a taper for the pregnant individual and the fetus.”
From Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits (2025) · cites this paper as [186]
In the citing paper
“For example, three guidelines offered explicit advice to use agents such as lorazepam, temazepam, oxazepam or brotizolam, which either undergo limited hepatic metabolism or have relatively shorter elimination half-lives to minimise theoretic fetal or lactational exposure.32,34,55”
In the citing paper
“BZD treatment specifications were provided more often in the context of perinatal/post-partum depressive disorders.32,34,55”
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tables
Guyatt, G., Oxman, A. D., Akl, E. A., Kunz, R., Vist, G., Brozek, J., Norris, S., Falck-Ytter, Y., Glasziou, P., & deBeer, H. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.04.026 · Cited by 10,681 · cited 1×
“A modified GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence-to-decision framework was applied to interpret and translate the evidence into draft recommendation statements, which were classified by strength and evidence quality (54, 55).”
MethodThe United Nations Development Programme
Oestreich, J. E. (2017) · Development and Human Rights · doi:10.1093/acprof:oso/9780190637347.003.0003 · Cited by 4,894
Cipriani, A., Furukawa, T. A., Salanti, G., Chaimani, A., Atkinson, L. Z., Ogawa, Y., Leucht, S., Ruhe, H. G., Turner, E. H., Higgins, J. P. T., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32802-7 · Cited by 3,541
Antenatal risk factors for postpartum depression: a synthesis of recent literature
Robertson, E., Grace, S., Wallington, T., & Stewart, D. E. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2004.02.006 · Cited by 1,886 · cited 1×
“Anxiety disorders are often comorbid with perinatal depression (38), and, even if not immediately comorbid, prenatal anxiety disorders are strong harbingers of postpartum depression (39, 40).”
BackgroundCipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement
Siu, A. L., and the US Preventive Services Task Force (USPSTF), Bibbins-Domingo, K., Grossman, D. C., Baumann, L. C., Davidson, K. W., Ebell, M., García, F. A. R., Gillman, M., Herzstein, J., et al. (2016) · JAMA · doi:10.1001/jama.2015.18392 · Cited by 1,407
Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., Rosenbaum, S., & Correll, C. U. (2015) · World Psychiatry · doi:10.1002/wps.20252 · Cited by 1,271 · cited 1×
“( STRONG REC-OMMENDATION, MODERATE-QUALITY EVIDENCE) Many of the existing antipsychotic medications are associated with metabolic side effects, including weight gain (172) and metabolic syndrome (173), including insulin resistance.”
BackgroundWisner, K. L., Sit, D. K. Y., McShea, M. C., Rizzo, D. M., Zoretich, R. A., Hughes, C. L., Eng, H. F., Luther, J. F., Wisniewski, S. R., Costantino, M. L., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.87 · Cited by 1,091 · cited 7×
“During pregnancy or postpartum, approximately one in five women will develop an incident mental health condition (4).”
BackgroundInfluentialCohen, L. S. (2006) · JAMA · doi:10.1001/jama.295.5.499 · Cited by 1,031
Research works printed but not linked: 1
- Samrén, 1999, Antiepileptic drug regimens and major congenital abnormalities in the offspring, Ann Neurol, 46, 739, 10.1002/1531-8249(199911)46:5<739::AID-ANA9>3.0.CO;2-2 · doi:10.1002/1531-8249(199911)46:5<739::aid-ana9>3.0.co;2-2
Cited by
ACOG Committee on Clinical Practice Guidelines–Obstetrics (2023) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000005200 · Cited by 294
Brandt, J., Bressi, J., Lê, M.-L., Neal, D., Cadogan, C., Witt-Doerring, J., Witt-Doerring, M., & Wright, S. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102507 · Cited by 77
“32,34,55 This could be explained by the emphasis on explicit safety considerations around medication use in pregnancy.”
BackgroundPostpartum Depression—New Screening Recommendations and Treatments
Simas, T. A. M., Whelan, A., & Byatt, N. (2023) · JAMA · doi:10.1001/jama.2023.21311 · Cited by 66
Khamidullina, Z., Marat, A., Muratbekova, S., Mustapayeva, N. M., Chingayeva, G. N., Shepetov, A. M., Ibatova, S. S., Terzic, M., & Aimagambetova, G. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072418 · Cited by 63
“The management of PPD typically involves a combination of different treatment methods: psychological, pharmacological, and lifestyle interventions, as well as family and social support (Figure 3) [7,104–108].”
InfluentialBrunner, E., Chen, C.-Y. A., Klein, T., Maust, D., Mazer-Amirshahi, M., Mecca, M., Najera, D., Ogbonna, C., Rajneesh, K. F., Roll, E., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09499-2 · Cited by 51
“175,186 In general, existing clinical guidelines recommend optimizing alternative therapeutic approaches (e.g., CBT, CBT-I) and advise caution with BZD dosing during pregnancy.”
Metadata
- Authors
- ACOG Committee on Clinical Practice Guidelines–Obstetrics
- Venue
- Obstetrics & Gynecology
- Published
- 2023-06
- Volume
- 141
- Issue
- 6
- Pages
- 1262-1288
- ISSN
- 0029-7844 (ISSN-L)
- 1873-233X
- OpenAlex
- W4377013002
- Cited by
- 252
- References
- 164
- Citations by year
- 2026: 91 · 2025: 84 · 2024: 62 · 2023: 14
- FWCI
- 64.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- perinatal mental health, psychiatric medication, psychopharmacological treatment, antenatal depression, anxiety disorders, bipolar disorder, postpartum psychosis, lactation, drug safety in pregnancy, drug efficacy
- MeSH terms
- Anxiety, Breast Feeding, Female, Humans, Lactation, Mental Health, Obstetrics, Pregnancy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ACOG Clinical Practice Guideline No. 5: Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum. https://app.cochat.ai/papers/10.1097/aog.0000000000005202
- The paper
- ACOG Committee on Clinical Practice Guidelines–Obstetrics. (2023). ACOG Clinical Practice Guideline No. 5: Treatment and Management of Mental Health Conditions During Pregnancy and Postpartum. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000005202
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.